Clinical trials
Terminated Phase 2 Lung Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Complexa, Inc. | 2 |
| Celgene | 1 |
| Eli Lilly and Company | 1 |
| Fundación GECP | 1 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
| Mallinckrodt | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Rhode Island Hospital | 1 |
| Sarah Goldberg | 1 |
| University of Milan | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Diseases | 13 |
| Hypertension, Pulmonary | 3 |
| Lung Neoplasms | 3 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Cardiovascular Diseases | 2 |
| Connective Tissue Diseases | 2 |
| Familial Primary Pulmonary Hypertension | 2 |
| Fibrosis | 2 |
| Hypertension | 2 |
| Pathologic Processes | 2 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.